Literature DB >> 24987754

Automated identification of brain new lesions in multiple sclerosis using subtraction images.

Marco Battaglini1, Francesca Rossi, Richard A Grove, Maria Laura Stromillo, Brandon Whitcher, Paul M Matthews, Nicola De Stefano.   

Abstract

PURPOSE: To propose and evaluate a new automated method for the identification of new/enlarging multiple sclerosis (MS) lesions on subtracted images (SI). The subtraction of serially acquired images has shown great potential in assessing new/enlarging brain magnetic resonance imaging (MRI) lesions in MS patients. However, this approach relies on the manual definition of lesions, which is labor-intensive and subject to operator-dependent variability.
MATERIALS AND METHODS: An overestimated mask of candidate SI lesions was created and then these hyperintense voxel clusters were filtered using specific constraints for extent, shape, and intensity. The method was tested on normal and pathological MRI datasets.
RESULTS: The automated method did not detect hyperintense voxels on SI of healthy controls. SI lesions were identified manually and automatically in a multicenter MS dataset of 19 patients with paired MRI over 36 weeks. Sensitivity of the method was high (0.91) and in agreement with the results of manually defined SI lesions (Cohen's k=0.82,95% confidence interval [CI]: 0.77–0.87). On a second multicenter MS dataset of 103 patients with paired MRI over 76 weeks, the number of SI lesions detected automatically correlated with the number of gadolinium-enhancing lesions(r=0.74).
CONCLUSION: The proposed method is robust, accurate,and sensitive and may be used with confidence in Phase II MS trials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24987754     DOI: 10.1002/jmri.24293

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  22 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients.

Authors:  Mike P Wattjes; Àlex Rovira; David Miller; Tarek A Yousry; Maria P Sormani; Maria P de Stefano; Mar Tintoré; Cristina Auger; Carmen Tur; Massimo Filippi; Maria A Rocca; Franz Fazekas; Ludwig Kappos; Chris Polman
Journal:  Nat Rev Neurol       Date:  2015-09-15       Impact factor: 42.937

2.  A toolbox for multiple sclerosis lesion segmentation.

Authors:  Eloy Roura; Arnau Oliver; Mariano Cabezas; Sergi Valverde; Deborah Pareto; Joan C Vilanova; Lluís Ramió-Torrentà; Àlex Rovira; Xavier Lladó
Journal:  Neuroradiology       Date:  2015-07-31       Impact factor: 2.804

3.  Longitudinal multiple sclerosis lesion segmentation: Resource and challenge.

Authors:  Aaron Carass; Snehashis Roy; Amod Jog; Jennifer L Cuzzocreo; Elizabeth Magrath; Adrian Gherman; Julia Button; James Nguyen; Ferran Prados; Carole H Sudre; Manuel Jorge Cardoso; Niamh Cawley; Olga Ciccarelli; Claudia A M Wheeler-Kingshott; Sébastien Ourselin; Laurence Catanese; Hrishikesh Deshpande; Pierre Maurel; Olivier Commowick; Christian Barillot; Xavier Tomas-Fernandez; Simon K Warfield; Suthirth Vaidya; Abhijith Chunduru; Ramanathan Muthuganapathy; Ganapathy Krishnamurthi; Andrew Jesson; Tal Arbel; Oskar Maier; Heinz Handels; Leonardo O Iheme; Devrim Unay; Saurabh Jain; Diana M Sima; Dirk Smeets; Mohsen Ghafoorian; Bram Platel; Ariel Birenbaum; Hayit Greenspan; Pierre-Louis Bazin; Peter A Calabresi; Ciprian M Crainiceanu; Lotta M Ellingsen; Daniel S Reich; Jerry L Prince; Dzung L Pham
Journal:  Neuroimage       Date:  2017-01-11       Impact factor: 6.556

4.  Improved Detection of New MS Lesions during Follow-Up Using an Automated MR Coregistration-Fusion Method.

Authors:  A Galletto Pregliasco; A Collin; A Guéguen; M A Metten; J Aboab; R Deschamps; O Gout; L Duron; J C Sadik; J Savatovsky; A Lecler
Journal:  AJNR Am J Neuroradiol       Date:  2018-06-07       Impact factor: 3.825

Review 5.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

6.  A novel imaging technique for better detecting new lesions in multiple sclerosis.

Authors:  Paul Eichinger; Hanni Wiestler; Haike Zhang; Viola Biberacher; Jan S Kirschke; Claus Zimmer; Mark Mühlau; Benedikt Wiestler
Journal:  J Neurol       Date:  2017-07-29       Impact factor: 4.849

Review 7.  Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Authors:  Claudio Gasperini; Luca Prosperini; Mar Tintoré; Maria Pia Sormani; Massimo Filippi; Jordi Rio; Jacqueline Palace; Maria A Rocca; Olga Ciccarelli; Frederik Barkhof; Jaume Sastre-Garriga; Hugo Vrenken; Jette L Frederiksen; Tarek A Yousry; Christian Enzinger; Alex Rovira; Ludwig Kappos; Carlo Pozzilli; Xavier Montalban; Nicola De Stefano
Journal:  Neurology       Date:  2018-12-26       Impact factor: 9.910

Review 8.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

9.  A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.

Authors:  Onur Ganiler; Arnau Oliver; Yago Diez; Jordi Freixenet; Joan C Vilanova; Brigitte Beltran; Lluís Ramió-Torrentà; Alex Rovira; Xavier Lladó
Journal:  Neuroradiology       Date:  2014-03-04       Impact factor: 2.804

10.  Improved Automatic Detection of New T2 Lesions in Multiple Sclerosis Using Deformation Fields.

Authors:  M Cabezas; J F Corral; A Oliver; Y Díez; M Tintoré; C Auger; X Montalban; X Lladó; D Pareto; À Rovira
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.